WO1998022156A1 - Oesophage artificiel - Google Patents
Oesophage artificiel Download PDFInfo
- Publication number
- WO1998022156A1 WO1998022156A1 PCT/JP1997/004204 JP9704204W WO9822156A1 WO 1998022156 A1 WO1998022156 A1 WO 1998022156A1 JP 9704204 W JP9704204 W JP 9704204W WO 9822156 A1 WO9822156 A1 WO 9822156A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- collagen
- layer
- esophagus
- tube
- microfibrillated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
Definitions
- an artificial material composed of a biological material or a polymer material is used.
- an artificial esophagus that promotes regeneration and regenerates the esophagus and does not allow artificial materials to remain after esophageal reconstruction an artificial esophagus in which a collagen coating layer is formed on the outer surface of a silicone tube (Japanese Patent Application Laid-Open No. 2009-0956) No. 9) has been reported.
- the collagen coating layer in this artificial esophagus swells and softens upon contact with bodily fluids, making it difficult to suture, and requires an advanced technique for the operator. In the case of an operator who does not have a high level of skill, bleeding and air leakage from a sutured portion are liable to occur. It can be fatal.
- the unique effect of collagen which promotes regeneration of the esophageal epithelium in the esophageal defect and regenerates the esophagus, can be maintained for a required time, and the foreign body is decomposed and absorbed by the living body as the esophagus is regenerated and the foreign substance is introduced into the living body. It has physical properties (strength) that does not require advanced techniques for the operator performing the suturing without leaving it, there is no bleeding or air leakage from the suturing area, and the stent is easily removed after reconstruction of the esophagus The development of an artificial esophagus that can be used has been required.
- the present inventors have conducted intensive studies to solve the above problems, and as a result, have found that an artificial esophagus having a microfibrillar collagen layer has an excellent effect, and have completed the present invention. .
- the present invention is an artificial esophagus having a microfibrotic collagen layer on the outer surface of a tube.
- the present invention also relates to a method for producing the artificial esophagus, comprising the steps of forming a microfibrillar collagen layer on the outer surface of a tube; and subjecting the tube to a crosslinking treatment.
- the artificial esophagus of the present invention is an artificial esophagus having a nonwoven fabric-like collagen layer in which fine fibers composed of collagen molecules are multiply folded on the outside of a tube serving as a core material for maintaining a lumen. .
- the thickness of this microfibrillated collagen layer is preferably about 2 to 10 mm, in particular about
- the tube as the core material for maintaining the lumen, for example, a tube made of a medical silicone sheet (thickness: preferably about 0.5 to 5 mnu, particularly about 1 to 2 mm) is used. Since the artificial esophagus of the present invention is sutured to a living body together with a tube which is a core material for maintaining a lumen, the inner diameter of the tube used is preferably about 15 to 30, particularly about 20. It can be different in some cases. The length of the tube can also vary depending on the application.
- the artificial esophagus of the present invention has a strength that can be easily sutured by itself, but when a higher strength is required, at least one side of the microfibrillar collagen layer (outside) is required. Side), a layer of a collagen film may be further provided. Unlike the microfibrillar collagen layer, the collagen film is an amorphous collagen film in which collagen molecules are dispersed in a monomer-oligomeric state.
- Collagen which is a raw material of the microfibrillated collagen layer of the artificial esophagus of the present invention may be any of conventionally used collagens, preferably neutral solubilized collagen, acid-soluble collagen, alkali-soluble collagen, or It is an enzyme-solubilized collagen.
- alkali-solubilized collagen and enzyme-solubilized collagen are those obtained by treating insoluble collagen with alkali or an enzyme (for example, pepsin, trypsin, chymotrypsin, papine, pronase, etc.). By these treatments, the highly antigenic telopeptide portion in the collagen molecule is removed and the antigenicity is reduced, so that it can be used particularly preferably.
- the origin of these collagens is not particularly limited, and is generally obtained by extracting and purifying from the skin, bones, cartilage, tendons, organs, and the like of animals such as sea lions, bushes, egrets, sheep, hidge, kangaroos, and birds. Can be used.
- a tube as a core material for maintaining the lumen of the artificial esophagus for example, the outer surface of a tube made of a medical silicone sheet as described above, is finely ground.
- a fibrillar collagen layer is finely ground.
- the microfibrotic collagen layer can be preferably formed on the outer surface of the tube by the following method. First, about 1N hydrochloric acid solution (about pH 3) of collagen after extraction and purification as described above (preferably about 0.5 to 3% by weight, especially about 1% by weight), and immerse the above tube (a rod-shaped core material, for example, a Teflon rod may be used) in a collagen hydrochloride solution. A uniform thickness of the collagen hydrochloride solution layer is formed on the outer surface of the tube by a method such as fitting the body and closing it. The thickness of the collagen hydrochloride solution layer is preferably about 20 to 10 Omm, particularly about 50 mm.
- This is preferably frozen at about 15 to 0 ° C, especially about 0 ° C, preferably for about 6 to 24 hours, especially for about 12 hours.
- fine ice is formed between the collagen molecules dispersed in the hydrochloric acid solution, the collagen hydrochloric acid solution undergoes layer separation, and the collagen molecules rearrange to form microfibrils.
- the above-mentioned silicone tube having the frozen collagen hydrochloride solution layer on its outer surface is placed under vacuum, preferably at about 15 to 0 ° C, particularly at about 0 ° C, and preferably at about 12 to 48 ° C. Freeze dry for about 24 hours, especially for about 24 hours.
- the tube having the microfibrillated collagen layer on its outer surface is uniformly compressed using a press device.
- the thickness of the microfibrillated collagen layer after compression is preferably about 2 to 10 mm, particularly about 5 mm.
- the compression ratio which is the ratio of the thickness of the layer of collagen before compression to the thickness of the layer of collagen before compression, is preferably from about 0.05 to 0.3, especially about 0.1.
- the tube having the microfibrillar collagen layer formed on the outer surface thereof is subjected to a crosslinking treatment.
- a crosslinking treatment By subjecting to cross-linking treatment, It is adjusted so that the artificial esophagus can be left for a desired period after it is applied to the living body.
- the cross-linking method include a cross-linking method using a ray, an electron beam, an ultraviolet ray, Daltar aldehyde, and epoxy, or a thermal dehydration cross-linking method using heat, and the degree of cross-linking is controlled. It is preferable to perform thermal dehydration crosslinking in which the effect of the crosslinking agent on the living body does not matter.
- the tube formed with the collagen layer obtained above is placed under vacuum, preferably at about 105 to 150 ° C, and particularly at about 120 to 150 ° C. Heat at C, preferably for about 6 to 24 hours, especially for about 6 to 12 hours. If the temperature is less than about 105 ° C., a sufficient crosslinking reaction does not occur. On the other hand, when the temperature exceeds about 150 ° C, collagen is denatured.
- a core material is used instead of the tube, the core material may be removed from the crosslinked tube, and a silicone tube may be fitted into the tube lumen.
- the artificial esophagus according to the present invention which has a microfibrillar collagen layer on the outer surface of the tube, has strength that can be easily combined by itself, but requires higher strength.
- a collagen film having an amorphous structure as described above may be further formed on at least one side (outside) of the microfibrillated collagen layer.
- An artificial esophagus having a microfibrillar collagen layer having a collagen film formed on the outside thereof can be prepared as follows.
- the extracted and purified collagen prepared in the same manner as described above was placed on the outer surface of the tube (a core material may be used as described above) having a microfibrillar collagen layer formed on its outer surface, prepared by the above method.
- About 1 N hydrochloric acid solution (pH about 3) (collagen concentration is preferably about 0.5 to 3% by weight, (Particularly about 1% by weight) to form a uniform thickness of collagen hydrochloride solution layer and dry it (this collagen solution layer formation and drying operation is repeated several times, preferably about 10 times) .
- the thickness of the collagen hydrochloride solution layer is preferably about 5 to 20 mm, particularly about 5 to 10 mm.
- a layer of an amorphous collagen film in which collagen molecules are dispersed is formed outside the microfibrillated collagen layer.
- the above-mentioned thermal dehydration crosslinking is performed on the thing in this state.
- the core material is replaced with a silicone tube after crosslinking, as described above.
- the artificial esophagus in which a layer of an amorphous collagen film is formed on both sides of the microfibrillated collagen layer is replaced by a rod-shaped core rod instead of a silicone tube when the microfibrillated collagen layer is formed.
- a tube made of only fibrillated collagen is prepared, and then the tube is immersed in the same collagen hydrochloride solution as described above to form a uniform thickness on the inner and outer surfaces of the microfibrillated collagen layer.
- the collagen hydrochloride solution layer may be formed and dried (similar to the above, the formation of the collagen solution layer and the drying operation are repeated several times). Also in this case, the thickness of the formed collagen hydrochloride solution layer is the same as that formed on the outer surface only. In addition, thermal dehydration cross-linking is also performed for those in this state.
- the core rod is removed, and the silicone tube is fitted into the lumen of a microfibrillated collagen tube having a collagen film having an amorphous structure on both sides.
- the state of the nonwoven-shaped fray on the surface of the microfibrillated collagen layer is changed to an amorphous collagen film.
- a part of the collagen having the amorphous structure penetrates into the microfibrillated collagen layer, so that the physical properties of the artificial esophagus of the present invention are further increased, and the suturing property and persistence in the body are improved. It will be better.
- b_FGF fibroblast growth factor
- PBS phosphate buffer solution
- a Teflon rod of about 9 cm in length and about 22 mm in diameter is immersed in a 1 N hydrochloric acid solution containing about 1% by weight of enzyme-solubilized collagen derived from porcine skin.
- a collagen hydrochloric acid solution having a thickness of about 50 mm was formed and frozen at about 0 ° C. for about 12 hours. This was freeze-dried under vacuum at about 0 ° C. for about 24 hours to obtain a collagen hydrochloride solution layer as a microfibrillated collagen layer.
- the microfibrillated collagen layer was compressed using a Teflon rod with a microfibrillated collagen layer formed on the surface until the thickness of the microfibrillated collagen layer was about 5 mm.
- a tissue having a compressed microfibrillated collagen layer on its surface The fluorocarbon rod was immersed again in the collagen hydrochloride solution to form a collagen hydrochloride solution layer on the outer surface of the microfibrillated collagen layer, and then air-dried. This immersion in collagen hydrochloride solution and air drying were repeated 10 times to form a 0.5 mm thick collagen film layer with an amorphous structure on the outer surface of the microfibrillated collagen layer.
- the Teflon rod having both collagen layers on its outer surface was further heated under a vacuum at 105 ° C. for 12 hours, and the collagen layer was subjected to a thermal dehydration crosslinking treatment. Then, the Teflon rod was removed, and a silicone tube having a length of about 9 cm, an inner diameter of about 20 mm, and a thickness of about 1 mm was fitted into the lumen of the tube composed of both collagen layers.
- a solution prepared by dissolving 280 mg of gelatin hydrogel microsphere containing b-FGFIOzg in 1 ml of PBS was injected into the collagen layer.
- the present invention is much more remarkable. It was confirmed that it was excellent.
- the artificial esophagus of the present invention has superior physical properties and particularly excellent suturing properties as compared with the conventional artificial esophagus, and therefore requires advanced techniques for the operator to be sutured like the conventional artificial esophagus. Therefore, almost no air leakage or bleeding from the joint due to the skill of the operator's suturing technique was observed. No.
- the collagen layer does not immediately dissolve after application to the living body, and promotes the regeneration and epithelialization of esophageal tissue while maintaining its shape for a desired period of time. Penetrates into the layer consisting of collagen and grows using the layer consisting of collagen as a foothold, regenerates the esophagus and gradually replaces the layer of collagen that is degraded and absorbed.
- the artificial esophagus of the present invention retains the collagen-specific effect of promoting regeneration of the esophageal epithelium in the esophageal defect and regenerating the esophagus for a predetermined period of time. Since it does not remain in the body and has strength enough to withstand suturing alone, there is no bleeding or air leakage from the suturing part due to the skill of the operator's suturing technique, and the stent is easily removed after reconstruction of the esophagus Therefore, it can be suitably used.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97912505A EP0943345A4 (en) | 1996-11-20 | 1997-11-19 | ARTIFICIAL EYES |
US09/308,556 US6241774B1 (en) | 1996-11-20 | 1997-11-19 | Artificial esophagus |
CA002272071A CA2272071A1 (en) | 1996-11-20 | 1997-11-19 | Artificial esophagus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30885596 | 1996-11-20 | ||
JP8/308855 | 1996-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998022156A1 true WO1998022156A1 (fr) | 1998-05-28 |
Family
ID=17986082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/004204 WO1998022156A1 (fr) | 1996-11-20 | 1997-11-19 | Oesophage artificiel |
Country Status (7)
Country | Link |
---|---|
US (1) | US6241774B1 (ja) |
EP (1) | EP0943345A4 (ja) |
KR (1) | KR20000057130A (ja) |
CN (1) | CN1237912A (ja) |
CA (1) | CA2272071A1 (ja) |
TW (1) | TW510803B (ja) |
WO (1) | WO1998022156A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009540896A (ja) * | 2006-06-22 | 2009-11-26 | オルトーム | コラーゲン・チューブ |
US10517994B2 (en) | 2009-07-22 | 2019-12-31 | Acell, Inc. | Variable density tissue graft composition and methods of making and using the same |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030225355A1 (en) * | 1998-10-01 | 2003-12-04 | Butler Charles E. | Composite material for wound repair |
US6398808B1 (en) * | 1999-06-15 | 2002-06-04 | Scimed Life Systems, Inc. | Localized delivery of genetic information from biostable materials |
WO2002015951A2 (en) | 2000-08-23 | 2002-02-28 | Thoratec Corporation | Coated vascular grafts and methods of use |
US20030114061A1 (en) * | 2001-12-13 | 2003-06-19 | Kazuhisa Matsuda | Adhesion preventive membrane, method of producing a collagen single strand, collagen nonwoven fabric and method and apparatus for producing the same |
EP1494597A4 (en) * | 2002-04-01 | 2006-05-03 | Univ Texas | COMPOSITE MATERIAL FOR THE WOUND REPAIR |
WO2007084278A2 (en) * | 2006-01-06 | 2007-07-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix based gastroesophageal junction reinforcement device |
US9474833B2 (en) * | 2006-12-18 | 2016-10-25 | Cook Medical Technologies Llc | Stent graft with releasable therapeutic agent and soluble coating |
US9005275B2 (en) | 2011-11-18 | 2015-04-14 | Mayo Foundation For Medical Education And Research | Methods for replacing a circumferential segment of an esophagus |
US10213526B2 (en) | 2014-03-21 | 2019-02-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix |
CN110352061A (zh) | 2017-03-02 | 2019-10-18 | 联邦高等教育系统匹兹堡大学 | 用于治疗食管炎症的ecm水凝胶 |
KR102048418B1 (ko) | 2017-12-08 | 2019-11-25 | 한림대학교 산학협력단 | 3d 프린팅으로 형성되며 장막-배양으로 보강된 인공 식도 및 그 제조방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57115250A (en) * | 1981-01-09 | 1982-07-17 | Unitika Ltd | Tubular artificial organ |
JPS60203264A (ja) * | 1984-01-30 | 1985-10-14 | メドツクス・メデイカルズ・インコ−ポレ−テツド | コラ−ゲン合成血管移植組織 |
JPH01110366A (ja) * | 1987-10-26 | 1989-04-27 | Olympus Optical Co Ltd | 人工管腔臓器 |
JPH02109569A (ja) * | 1988-10-19 | 1990-04-23 | Nippon Ham Kk | 人工食道 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3272304A (en) | 1965-05-10 | 1966-09-13 | Royal Typewriter Co Inc | Typewriter ribbon package |
US3272204A (en) * | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
US4842575A (en) | 1984-01-30 | 1989-06-27 | Meadox Medicals, Inc. | Method for forming impregnated synthetic vascular grafts |
US5108424A (en) | 1984-01-30 | 1992-04-28 | Meadox Medicals, Inc. | Collagen-impregnated dacron graft |
US4600533A (en) * | 1984-12-24 | 1986-07-15 | Collagen Corporation | Collagen membranes for medical use |
US4948540A (en) * | 1988-08-01 | 1990-08-14 | Semex Medical, Inc. | Method of preparing collagen dressing sheet material |
JP2678945B2 (ja) * | 1989-04-17 | 1997-11-19 | 有限会社ナイセム | 人工血管とその製造方法及び人工血管用基質 |
US5026381A (en) * | 1989-04-20 | 1991-06-25 | Colla-Tec, Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit |
SE467739B (sv) * | 1991-04-05 | 1992-09-07 | Collagen Casing Einar Sjoeland | Foerfarande foer framstaellning av kollagen och kollagen framstaellt genom foerfarandet samt anvaendning av kollagen |
US5607590A (en) * | 1993-08-06 | 1997-03-04 | Shimizu; Yasuhiko | Material for medical use and process for preparing same |
AU2124395A (en) | 1994-03-21 | 1995-10-09 | Thomas V Ortolivo | Glove for washing pets |
WO1995025482A1 (en) * | 1994-03-22 | 1995-09-28 | Organogenesis, Inc. | Three-dimensional bioremodelable collagen fabrics |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5993844A (en) * | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
US6090996A (en) * | 1997-08-04 | 2000-07-18 | Collagen Matrix, Inc. | Implant matrix |
-
1997
- 1997-11-18 TW TW086117183A patent/TW510803B/zh active
- 1997-11-19 KR KR1019990704397A patent/KR20000057130A/ko active IP Right Grant
- 1997-11-19 EP EP97912505A patent/EP0943345A4/en not_active Withdrawn
- 1997-11-19 US US09/308,556 patent/US6241774B1/en not_active Expired - Fee Related
- 1997-11-19 CA CA002272071A patent/CA2272071A1/en not_active Abandoned
- 1997-11-19 CN CN97199862A patent/CN1237912A/zh active Pending
- 1997-11-19 WO PCT/JP1997/004204 patent/WO1998022156A1/ja active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57115250A (en) * | 1981-01-09 | 1982-07-17 | Unitika Ltd | Tubular artificial organ |
JPS60203264A (ja) * | 1984-01-30 | 1985-10-14 | メドツクス・メデイカルズ・インコ−ポレ−テツド | コラ−ゲン合成血管移植組織 |
JPH01110366A (ja) * | 1987-10-26 | 1989-04-27 | Olympus Optical Co Ltd | 人工管腔臓器 |
JPH02109569A (ja) * | 1988-10-19 | 1990-04-23 | Nippon Ham Kk | 人工食道 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0943345A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009540896A (ja) * | 2006-06-22 | 2009-11-26 | オルトーム | コラーゲン・チューブ |
US10517994B2 (en) | 2009-07-22 | 2019-12-31 | Acell, Inc. | Variable density tissue graft composition and methods of making and using the same |
Also Published As
Publication number | Publication date |
---|---|
US6241774B1 (en) | 2001-06-05 |
EP0943345A4 (en) | 2000-12-27 |
CN1237912A (zh) | 1999-12-08 |
KR20000057130A (ko) | 2000-09-15 |
CA2272071A1 (en) | 1998-05-28 |
EP0943345A1 (en) | 1999-09-22 |
TW510803B (en) | 2002-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100461475B1 (ko) | 콜라겐재 및 그 제법 | |
Chvapil | Considerations on manufacturing principles of a synthetic burn dressing: a review | |
JP3784798B2 (ja) | ポリテトラフルオロエチレン製の埋め込み可能なチューブ状プロテーゼ | |
US7084082B1 (en) | Collagen material and its production process | |
EP0140596B1 (en) | Protein/polysaccharide complexes | |
JPH11508151A (ja) | 膀胱再建方法及び膀胱再建用組織グラフト | |
WO1998024385A1 (fr) | Vaisseau sanguin artificiel | |
JP4968976B2 (ja) | コラーゲン材及びその製法 | |
WO1998022156A1 (fr) | Oesophage artificiel | |
JP3726280B2 (ja) | 医療用コラーゲン膜 | |
JPH06292716A (ja) | 医用材料 | |
CN113301928A (zh) | 生物支架和用于制备其的方法 | |
JP2013516201A (ja) | 複合母材 | |
JP4595279B2 (ja) | 癒着防止膜 | |
JP2010029684A (ja) | コラーゲン材及びその製法 | |
JP2001346866A (ja) | ハイブリッド樹脂材料およびその製造方法 | |
JP4496425B2 (ja) | 人工喉頭 | |
CN114796607A (zh) | 基于胶原蛋白纳米纤维填充的生物材料、预制品及其制备和应用 | |
JPH0759841A (ja) | 細胞侵入性医用材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97199862.0 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA CN JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2272071 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997004397 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09308556 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997912505 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997912505 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997004397 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997912505 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019997004397 Country of ref document: KR |